X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5939) 5939
Magazine Article (35) 35
Book Chapter (21) 21
Newsletter (13) 13
Conference Proceeding (3) 3
Book / eBook (2) 2
Book Review (1) 1
Dissertation (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5177) 5177
amiodarone - therapeutic use (3570) 3570
male (2904) 2904
anti-arrhythmia agents - therapeutic use (2618) 2618
female (2516) 2516
amiodarone (2479) 2479
middle aged (2135) 2135
aged (1957) 1957
cardiac & cardiovascular systems (1656) 1656
amiodarone - adverse effects (1428) 1428
adult (1186) 1186
atrial fibrillation - drug therapy (1101) 1101
atrial fibrillation (973) 973
anti-arrhythmia agents - adverse effects (923) 923
electrocardiography (909) 909
treatment outcome (827) 827
arrhythmias, cardiac - drug therapy (787) 787
pharmacology & pharmacy (767) 767
amiodarone - administration & dosage (703) 703
animals (611) 611
risk factors (567) 567
follow-up studies (537) 537
mortality (523) 523
therapy (485) 485
time factors (478) 478
medicine, general & internal (466) 466
amiodarone - pharmacology (462) 462
adrenergic beta-antagonists - therapeutic use (455) 455
anti-arrhythmia agents - administration & dosage (435) 435
cardiac arrhythmia (409) 409
tachycardia - drug therapy (409) 409
amiodarone - analogs & derivatives (408) 408
drug therapy (405) 405
aged, 80 and over (397) 397
atrial fibrillation - physiopathology (396) 396
defibrillators, implantable (390) 390
prevention (390) 390
benzofurans - therapeutic use (389) 389
retrospective studies (387) 387
sinus rhythm (378) 378
recurrence (370) 370
arrhythmias (366) 366
efficacy (364) 364
atrial fibrillation - therapy (361) 361
electric countershock (360) 360
drug therapy, combination (347) 347
care and treatment (341) 341
arrhythmia (337) 337
management (334) 334
heart rate - drug effects (331) 331
prospective studies (326) 326
tachycardia (313) 313
anti-arrhythmia agents - pharmacology (311) 311
dose-response relationship, drug (310) 310
tachycardia, ventricular - drug therapy (303) 303
myocardial-infarction (294) 294
heart (292) 292
adolescent (286) 286
medicine & public health (285) 285
atrial fibrillation - prevention & control (284) 284
heart failure (279) 279
sotalol - therapeutic use (279) 279
risk (277) 277
atrial fibrillation - etiology (274) 274
intravenous amiodarone (273) 273
atrial-fibrillation (266) 266
drug interactions (264) 264
prognosis (259) 259
cardiology (257) 257
abridged index medicus (252) 252
analysis (252) 252
clinical trials as topic (250) 250
electrophysiology (249) 249
catheter ablation (247) 247
surgery (241) 241
ventricular fibrillation - drug therapy (239) 239
heart failure - drug therapy (238) 238
cardiac pacing, artificial (237) 237
death, sudden, cardiac - prevention & control (236) 236
fibrillation (233) 233
randomized controlled trials as topic (231) 231
anti-arrhythmia drugs (229) 229
dronedarone (220) 220
administration, oral (215) 215
cardiovascular (213) 213
health aspects (212) 212
cardioversion (210) 210
antiarrhythmic drugs (202) 202
drugs (201) 201
tachycardia, ventricular - therapy (198) 198
arrhythmias, cardiac - physiopathology (194) 194
sotalol (189) 189
research (187) 187
ventricular tachycardia (182) 182
amiodarone - pharmacokinetics (180) 180
arrhythmias, cardiac - etiology (178) 178
child (177) 177
atrial fibrillation - complications (176) 176
low-dose amiodarone (176) 176
digoxin - therapeutic use (175) 175
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5190) 5190
French (194) 194
German (177) 177
Italian (138) 138
Russian (121) 121
Spanish (95) 95
Japanese (60) 60
Portuguese (44) 44
Polish (42) 42
Chinese (39) 39
Czech (12) 12
Hungarian (10) 10
Finnish (9) 9
Turkish (8) 8
Danish (7) 7
Hebrew (6) 6
Dutch (5) 5
Bulgarian (3) 3
Lithuanian (3) 3
Romanian (3) 3
Serbian (3) 3
Swedish (3) 3
Korean (2) 2
Croatian (1) 1
Icelandic (1) 1
Norwegian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Cardiology, The, ISSN 0002-9149, 2013, Volume 112, Issue 5, pp. 684 - 687
Journal Article
Journal Article
Journal of Cardiac Failure, ISSN 1071-9164, 2007, Volume 13, Issue 5, pp. 340 - 345
Abstract Background Uncertainty persists about the safety and efficacy of amiodarone for the management of heart failure. Methods and Results We randomized... 
Cardiovascular | Heart failure | mortality | sudden death | circulatory failure | amiodarone | heart failure | CAMIAT | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | EMIAT | COMET | RANDOMIZED-TRIAL | METOPROLOL | CARVEDILOL | EUROPEAN TRIAL | Multivariate Analysis | Humans | Middle Aged | Adrenergic alpha-Antagonists - therapeutic use | Death, Sudden, Cardiac - prevention & control | Male | Metoprolol - therapeutic use | Anti-Arrhythmia Agents - therapeutic use | Heart Failure - drug therapy | Amiodarone - adverse effects | Propanolamines - therapeutic use | Amiodarone - therapeutic use | Anti-Arrhythmia Agents - adverse effects | Female | Aged | Carbazoles - therapeutic use | Atrial Fibrillation - prevention & control | Adrenergic beta-Antagonists - therapeutic use | Heart Failure - mortality | Care and treatment | Amiodarone | Safety and security measures | Cardiac patients | Atrial Fibrillation/prevention & control | Heart Failure/drug therapy/mortality | Cardiac/prevention & control | Amiodarone/adverse effects/therapeutic use | Sudden | Adrenergic beta-Antagonists/therapeutic use | Kardiologi | Cardiac and Cardiovascular Systems | Adrenergic alpha-Antagonists/therapeutic use | Anti-Arrhythmia Agents/adverse effects/therapeutic use | Propanolamines/therapeutic use | Death | Carbazoles/therapeutic use | Metoprolol/therapeutic use
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 388, Issue 10046, pp. 818 - 828
Summary Control of the heart rate (rate control) is central to atrial fibrillation management, even for patients who ultimately require control of the rhythm.... 
Internal Medicine | REDUCED EJECTION FRACTION | CARDIAC RESYNCHRONIZATION THERAPY | TASK-FORCE | TORSADE-DE-POINTES | LONG-TERM SURVIVAL | STRICT RATE CONTROL | HEART RHYTHM ASSOCIATION | RATE CONTROL EFFICACY | VENTRICULAR RATE CONTROL | ATRIOVENTRICULAR JUNCTION ABLATION | RHYTHM-CONTROL | MEDICINE, GENERAL & INTERNAL | HEART-FAILURE | ASSOCIATION TASK-FORCE | BETA-BLOCKERS | Age Factors | Humans | Patient-Centered Care | Bradycardia - therapy | Calcium Channel Blockers - therapeutic use | Heart Failure - physiopathology | Catheter Ablation | Atrial Fibrillation - physiopathology | Pacemaker, Artificial | Sotalol - therapeutic use | Heart Rate - drug effects | Amiodarone - therapeutic use | Drug Therapy, Combination | Cardiac Resynchronization Therapy | Digoxin - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Atrial Fibrillation - drug therapy | Atrial Fibrillation - therapy | Anti-Arrhythmia Agents - therapeutic use | Atrial Fibrillation - surgery | Heart Failure - drug therapy | Randomized Controlled Trials as Topic | Atenolol - therapeutic use | Atrioventricular Node - surgery | Practice Guidelines as Topic | Heart failure | Heart | Ablation (Surgery) | Heart beat | Digoxin | Atrial fibrillation | Cardiac patients | Adrenergic beta blockers | Heart rate | Electrocardiography | Cardiac arrhythmia | Stroke | Mortality | Catheters
Journal Article
Journal Article
Canadian Journal of Cardiology, ISSN 0828-282X, 2011, Volume 27, Issue 1, pp. 47 - 59
Abstract The goals of atrial fibrillation (AF) and atrial flutter (AFL) arrhythmia management are to alleviate patient symptoms, improve patient quality of... 
Cardiovascular | CARDIAC & CARDIOVASCULAR SYSTEMS | INTRAVENOUS AMIODARONE | RENIN-ANGIOTENSIN SYSTEM | TORSADE-DE-POINTES | POLYUNSATURATED FATTY-ACIDS | FOLLOW-UP | ANTIARRHYTHMIC THERAPY | CONGESTIVE-HEART-FAILURE | VENTRICULAR RATE CONTROL | SINUS RHYTHM | ELECTRICAL CARDIOVERSION | Digoxin - adverse effects | Calcium Channel Blockers - adverse effects | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Catheter Ablation | Pacemaker, Artificial | Sotalol - therapeutic use | Dose-Response Relationship, Drug | Amiodarone - adverse effects | Heart Rate - drug effects | Sotalol - adverse effects | Amiodarone - therapeutic use | Adrenergic beta-Antagonists - adverse effects | Adult | Cardiac Output, Low - drug therapy | Drug Therapy, Combination | Digoxin - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Drug Administration Schedule | Atrial Fibrillation - drug therapy | Propafenone - adverse effects | Treatment Outcome | Anti-Arrhythmia Agents - therapeutic use | Cardiac Output, Low - complications | Amiodarone - analogs & derivatives | Flecainide - adverse effects | Canada | Myocardial Infarction - complications | Algorithms | Myocardial Infarction - drug therapy | Anti-Arrhythmia Agents - adverse effects | Atrial Fibrillation - etiology | Atrial Flutter - drug therapy | Aged | Propafenone - therapeutic use | Referral and Consultation | Flecainide - therapeutic use
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2008, Volume 358, Issue 25, pp. 2667 - 2677
Journal Article
The Journal of emergency medicine, ISSN 0736-4679, 2017, Volume 52, Issue 4, pp. e123 - e127
...) thought to be associated with ibrutinib, a TKI. The ES was unabated despite antidysrhythmic therapy and electrical cardioversion, and was treated with supportive care, which eventually included the use of extracorporeal membrane oxygenation... 
Emergency | ibrutinib | dysrhythmia | tyrosine kinase inhibitor | ventricular storm | torsades des pointes | electrical storm | MANAGEMENT | EMERGENCY MEDICINE | Lidocaine - pharmacology | Pyrazoles - therapeutic use | Respiration, Artificial - methods | Anti-Arrhythmia Agents - pharmacology | Humans | Middle Aged | Lidocaine - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Cardiotonic Agents - therapeutic use | Waldenstrom Macroglobulinemia - drug therapy | Amiodarone - therapeutic use | Antineoplastic Agents - adverse effects | Emergency Service, Hospital - organization & administration | Antineoplastic Agents - pharmacology | Torsades de Pointes - diagnosis | Torsades de Pointes - drug therapy | Electrocardiography - methods | Extracorporeal Membrane Oxygenation - methods | Amiodarone - pharmacology | Electric Countershock - methods | Pyrazoles - adverse effects | Pyrazoles - pharmacology | Tachycardia, Ventricular - therapy | Intra-Aortic Balloon Pumping - methods | Tachycardia, Ventricular - etiology | Anti-Arrhythmia Agents - therapeutic use | Cardiotonic Agents - pharmacology | Intensive Care Units - organization & administration | Pyrimidines - pharmacology | Magnesium - pharmacology | Electrophysiology - manpower | Magnesium - therapeutic use | Electrophysiology - methods | Pyrimidines - therapeutic use | Isoproterenol - pharmacology | Tachycardia, Ventricular - diagnosis | Pyrimidines - adverse effects | Syncope - etiology | Isoproterenol - therapeutic use | Tyrosine | Phenols | Tachycardia | Emergency medicine | Ventricular tachycardia | Risk factors
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 374, Issue 20, pp. 1911 - 1921
Journal Article